Immune to Cancer: The CRI Blog
-
Partner Spotlight: Thomas Hudson, Abbvie
We introduce you to Thomas Hudson, MD, vice president, head of oncology discovery and early development at…
-
Immuno-Oncology 360°: Taking Immunotherapy to the Next Level
By bringing together diverse stakeholders, IO360 hopes to facilitate the collaborations that will advance immunotherapy.
-
How Man’s Best Friend Could Help Us Cure Cancer
Cancer very is similar in dogs and humans, and scientists are now exploring how cures for one…
-
Immunotherapy is Here to Stay: Looking Back at this Year’s Breakthroughs
Important immunotherapy breakthroughs benefited patients immensely in 2017 and paved the way for even more advances in…
-
Recent FDA Announcements Herald Advances in Personalized Approaches Against Cancer
Two tumor-profiling tests recently authorized by the FDA enable doctors to tailor their treatments more effectively to…
-
Immunotherapy Shines at ASH and ESMO IO Conferences
Two conferences, one in America and one in Europe, highlight immunotherapy's continued progress and the important contributions…
-
Trusted Charities for Holiday Giving
Trusted consumer watchdog organizations make it a little easier to decide where to give this holiday season with…
-
Cindy Stowell Continues to Inspire
Jeopardy! host Alex Trebek will make a special announcement on Tuesday, November 7th.
-
CRI Researcher Highlights New Technique to Aid Immunotherapy
Dr. Mohammad Rashidian’s nanobodies could help improve doctors’ decisions regarding immunotherapy.
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.